Literature DB >> 8396739

Effects of different antihypertensive drugs on human diabetic proteinuria.

P Weidmann, L M Boehlen, M de Courten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396739

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  9 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  ACE inhibitors and proteinuria.

Authors:  R T Gansevoort; D de Zeeuw; P E de Jong
Journal:  Pharm World Sci       Date:  1996-12

Review 3.  Renal protection and antihypertensive drugs: current status.

Authors:  A Salvetti; P Mattei; I Sudano
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

Review 4.  Blood pressure lowering for the prevention and treatment of diabetic kidney disease.

Authors:  Merlin C Thomas; Robert C Atkins
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  How to titrate ACE inhibitors and angiotensin receptor blockers in renal patients: according to blood pressure or proteinuria?

Authors:  Julian Segura; Helle Christiansen; Carlos Campo; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

6.  Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.

Authors:  L D Elving; J F Wetzels; H J van Lier; E de Nobel; J H Berden
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

7.  Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.

Authors: 
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

8.  Evaluation of therapeutic effects of crocin in attenuating the progression of diabetic nephropathy: a preliminary randomized triple-blind placebo-controlled trial.

Authors:  Asma Jaafarinia; Behzad Kafami; Adeleh Sahebnasagh; Fatemeh Saghafi
Journal:  BMC Complement Med Ther       Date:  2022-10-08

9.  Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial.

Authors:  Yongchun Ge; Honglang Xie; Shijun Li; Bo Jin; Jinhua Hou; Haitao Zhang; Mingjun Shi; Zhihong Liu
Journal:  J Transl Med       Date:  2013-05-31       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.